In vitro experimental results showed that the anti-PD-1/PD-L1 antibody combined with lenalidomide could induce the apoptosis of MM cells and increase IFN-γ production in CD4+ and CD8+ T cells [41]. This evidence concerns the gene CD8A and Miyoshi myopathy.